Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Expert Review of Pharmacoeconomics & Outcomes Research|September 4, 2023
Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic reviewAna Parra, Claudia Hernández, Laura Prieto-PintoValue in Health Regional Issues|July 21, 2020
International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the LiteratureLaura Prieto-Pinto, Nathaly Garzón-Orjuela, Pieralessandro Lasalvia, et al.Lung Cancer Management|June 8, 2023
Alectinib for treating patients with metastatic Daniel Samacá-Samacá, Laura Prieto-Pinto, Andrés Yepes Peréz, et al.International Journal of Integrated Care|July 11, 2022
Integrated Maternal Care Strategies in Low- and Middle-Income Countries: A Systematic ReviewLaura van der Werf, Silvia Evers, Laura Prieto-Pinto, et al.BMJ Open Ophthalmology|July 23, 2024
Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysisDaniel Samacá-Samacá, Claudia Hernández-Castillo, Laura Prieto-Pinto, et al.Journal of Health Economics and Outcomes Research|February 23, 2026
Cost-Effectiveness Analysis of Trastuzumab-Emtansine as Adjuvant Therapy for HER2-Positive Early Breast Cancer with Residual Invasive Disease in ColombiaDaniel Samacá-Samacá, Diego Ballén, Milton Lombana, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 25, 2023
Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in ColombiaYaneth Gil-Rojas, Fernando Suárez-Obando, Devi Amaya-Granados, et al.Dermatologic Therapy|August 8, 2020
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysisNathaly Garzón-Orjuela, Laura Prieto-Pinto, Pieralessandro Lasalvia, et al.Dermatologic Therapy|October 31, 2019
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysisNathaly Garzón-Orjuela, Laura Prieto-Pinto, Pieralessandro Lasalvia, et al.Journal of Health Economics and Outcomes Research|March 7, 2025
Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in ColombiaDaniel Samacá-Samacá, Antonio Robles, Hugo Ocampo, et al.Pageof 2